XML 31 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) (USD $)
3 Months Ended 9 Months Ended
Feb. 28, 2013
Feb. 29, 2012
Feb. 28, 2013
Feb. 29, 2012
Revenue:        
Products $ 244 $ 530 $ 936 $ 1,166
Services 1,215 1,130 3,574 3,763
Royalties from sale of patents 0 0 290 0
Total revenue 1,459 1,660 4,800 4,929
Cost of revenue:        
Products, 38 38 88 54
Services, 293 342 924 1,026
Total cost of revenue 331 380 1,012 1,080
Gross margin 1,128 1,280 3,788 3,849
Research and development expenses 231 238 799 958
Selling, general and administrative expenses 848 830 2,391 2,257
Operating income 49 212 598 634
Interest expense 63 74 198 250
Other (income) expense 0 1 (11) 7
Net income(loss) $ (14) $ 137 $ 411 $ 377
Basic and diluted net income per share: $ (0.01) $ 0.14 $ 0.41 $ 0.38
Weighted average common shares outstanding-basic 1,039,302 995,135 1,009,567 995,135
Weighted average common shares outstanding-diluted 1,040,573 995,135 1,010,842 995,135